Our CRISPR platform is also designed to deliver therapeutic genes to commensal bacteria within the microbiome to enable in situ production & secretion of therapeutic proteins & peptides

Our CRISPR platform can deliver genes to the microbiome enabling in situ production of therapeutic proteins and peptides. 

Proteins and peptides can comprise enzymes that target unwanted metabolites from the microbiome, including anti-cytokines to dampen autoimmune inflammation in IBD, immune-oncology active antibodies, active signaling molecules/hormones like GLP-2, GIP, serotonin etc.